Artificial Pancreas With Different Stress Assessments in the Outpatient Setting

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
Type 1 Diabetes
Interventions
DEVICE

iAPS

The AID system (iAPS) is comprised of an insulin pump, a Dexcom G6 continuous glucose monitoring sensor, and a smart phone that contains the algorithm and communicates with the other devices.

OTHER

Sensor-Augmented Pump

Subjects will use their home insulin pump and a Dexcom G6 continuous glucose monitoring sensor.

Trial Locations (2)

55905

Mayo Clinic, Rochester

93105

Sansum Diabetes Research Institute, Santa Barbara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Harvard University

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT04142229 - Artificial Pancreas With Different Stress Assessments in the Outpatient Setting | Biotech Hunter | Biotech Hunter